BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12434955)

  • 1. Community pneumonia--more help is needed to diagnose and assess severity.
    Melbye H
    Br J Gen Pract; 2002 Nov; 52(484):886-8. PubMed ID: 12434955
    [No Abstract]   [Full Text] [Related]  

  • 2. Severity assessment in community-acquired pneumonia: a review.
    Singanayagam A; Chalmers JD; Hill AT
    QJM; 2009 Jun; 102(6):379-88. PubMed ID: 19299247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein is an independent predictor of severity in community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Hill AT
    Am J Med; 2008 Mar; 121(3):219-25. PubMed ID: 18328306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRP: a new prognosis marker in community-acquired pneumonia?
    Boussekey N; Van Grunderbeeck N; Leroy O
    Am J Med; 2008 Aug; 121(8):e21; author reply e23. PubMed ID: 18691466
    [No Abstract]   [Full Text] [Related]  

  • 5. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].
    Christ-Crain M; Morgenthaler NG; Stolz D; Müller C; Bingisser R; Harbarth S; Tamm M; Struck J; Bergmann A; Müller B
    Crit Care; 2006; 10(3):R96. PubMed ID: 16805922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narrowing in on JCAHO recommendations for community-acquired pneumonia.
    Rothman RE; Quianzon CC; Kelen GD
    Acad Emerg Med; 2006 Sep; 13(9):983-5. PubMed ID: 16946291
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study on the diagnostic test with C-reactive protein in elderly patients with infections].
    Hu XL; Wang L; Yang W; Yu W; Yue XH; Liu YH; Chu R; Wang Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Apr; 24(4):304-6. PubMed ID: 12820951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of infectious pneumonia: value of C-reactive protein.
    Gil H; Meaux Ruault N; Hafsaoui C; Dupond JL; Magy-Bertrand N
    Am J Med; 2009 May; 122(5):e11; author reply e13. PubMed ID: 19375533
    [No Abstract]   [Full Text] [Related]  

  • 9. C-reactive protein could predict pneumonia in COPD.
    Tanday S
    Lancet Respir Med; 2013 Sep; 1(7):510. PubMed ID: 24461608
    [No Abstract]   [Full Text] [Related]  

  • 10. Community pneumonia practice standard mandates: can't see the forest for the trees.
    Kelen GD; Rothman RE
    Acad Emerg Med; 2006 Sep; 13(9):986-8. PubMed ID: 16946292
    [No Abstract]   [Full Text] [Related]  

  • 11. Severity assessment in community-acquired pneumonia: moving on.
    Lim WS
    Thorax; 2007 Apr; 62(4):287-8. PubMed ID: 17387212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough.
    Flanders SA; Stein J; Shochat G; Sellers K; Holland M; Maselli J; Drew WL; Reingold AL; Gonzales R
    Am J Med; 2004 Apr; 116(8):529-35. PubMed ID: 15063814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of community-acquired pneumonia].
    Schaaf B; Rupp J
    Pneumologie; 2006 Sep; 60(9):547-54; quiz 555-8. PubMed ID: 17006790
    [No Abstract]   [Full Text] [Related]  

  • 14. [Factors that modify C-reactive protein production in patients with community-acquired pneumonia].
    Cabezas P; Ruiz-González A; Falguera M
    Arch Bronconeumol; 2010 Jan; 46(1):48-9. PubMed ID: 19656608
    [No Abstract]   [Full Text] [Related]  

  • 15. A case-control study of SARS versus community acquired pneumonia.
    Cheng FW; Ng PC; Chiu WK; Chu WC; Li AM; Lo KL; Hon EK; Nelson EA; Leung TF; Ng WH; Wong E; Ip P; Fok TF
    Arch Dis Child; 2005 Jul; 90(7):747-9. PubMed ID: 15970619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Admission D-dimer can identify low-risk patients with community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Scally C; Hill AT
    Ann Emerg Med; 2009 May; 53(5):633-8. PubMed ID: 19201061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CURB (confusion, urea, respiratory rate and blood pressure) criteria in community-acquired pneumonia (CAP) in hospitalised elderly patients aged 65 years and over: a prospective observational cohort study.
    Myint PK; Kamath AV; Vowler SL; Maisey DN; Harrison BD
    Age Ageing; 2005 Jan; 34(1):75-7. PubMed ID: 15591485
    [No Abstract]   [Full Text] [Related]  

  • 18. Procoagulant activity in children with community acquired pneumonia, pleural effusion and empyema.
    Michelin E; Snijders D; Conte S; Dalla Via P; Tagliaferro T; Da Dalt L; Monciotti CM; Simioni P; Stefanutti G; Ghirardo V; Gamba P; Barbato A
    Pediatr Pulmonol; 2008 May; 43(5):472-5. PubMed ID: 18383331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiographic, clinical, and prognostic features of complicated and uncomplicated community-acquired lobar pneumonia in children.
    Lin CJ; Chen PY; Huang FL; Lee T; Chi CS; Lin CY
    J Microbiol Immunol Infect; 2006 Dec; 39(6):489-95. PubMed ID: 17164952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia.
    Chalmers JD; Singanayagam A; Hill AT
    Thorax; 2008 Aug; 63(8):698-702. PubMed ID: 18492742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.